Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.42 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.41 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.41 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GPR39 | O43194 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.40 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18903839 | 0.85 | PTGS2 (0.47) | TLR4TLR2GRM5IP6K1IP6K3 | |
| SCHEMBL17602146 | 0.84 | TLR4 (0.48) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL12129555 | 0.82 | TLR4 (0.56) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL29612417 | 0.82 | TLR4 (0.56) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL30064803 | 0.82 | TLR4 (0.35) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL15602369 | 0.81 | TLR4 (0.55) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL8943978 | 0.80 | MAOB (0.48) | KDM4ESMN1; SMN2L3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL17602155 | 0.79 | KDM4C (0.50) | TLR4TLR2GRM5FFAR4IP6K1 | |
| SCHEMBL16890151 | 0.79 | MAOB (0.47) | KDM4ESMN1; SMN2L3MBTL1NPC1CYP1A2 | |
| SCHEMBL147539 | 0.78 | LOXL2 (0.52) | TLR4TLR2GRM5FFAR4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1683804-A2 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | Takasago International Corporation (JP) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070103060-A1 | Platinum complex and light emitting device | UBE2D3, PCID2, CCND2 | TLR4 2268/4885TLR2 2277/4885GRM5 1971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.